Advisory Board Member

ABOUT LUMAEGISLumaegis is developing a faster, simpler way for healthcare providers to sterilize medical and dental instruments.Its flagship product, RadBox™, is designed to sterilize instruments at the point of care in under six minutes — without water, steam, or chemical sterilants.Today, many sterilization processes can take significantly longer, require bulky equipment, or depend on outsourced services. These constraints can reduce efficiency, increase operating costs, and limit clinical capacity.RadBox is designed to provide a faster, more efficient alternative.Interested in learning more about this job Scroll down and find out what skills, experience and educational qualifications are needed.Potential benefits include:Faster instrument turnaroundImproved patient throughputReduced reliance on outsourced sterilizationLower instrument inventory requirementsZero water use and significantly reduced power consumptionGreater operational flexibility across healthcare settingsBehind this simple workflow is Lumaegis' patented dual-modality sterilization technology, designed for regulated healthcare environments.WHY LUMAEGISLumaegis is approaching one of the most important stages in its development.Recent milestones include:FDA De Novo pathway established, with the latest submission, Supplement 5, formally acknowledged by the FDAGLP microbiology testing protocol finalized ahead of FDA-required validationMultiple commercial Letters of Intent signed for deployment of RadBox™ systems following FDA clearanceDemonstrated a portable, battery-operated system to the Medical Future Capability Directorate, US Army Futures Command…generated extreme interest.Patent protection progressing across the United States and EuropeAcceptance for a podium presentation at the 2026 International Ultraviolet Association (IUVA) Americas ConferenceStrategic discussions underway with Singapore's Economic Development Board investment arm (EDBI) regarding potential investment and Asia-Pacific expansion supportThe company is targeting FDA marketing clearance in early 2027, subject to completion of the remaining regulatory milestones.Rather than building a concept, Lumaegis is now preparing for commercial launch.THE ADVISORY BOARDLumaegis is expanding its Advisory Board to include a select group of experienced leaders who can provide strategic insight as the company enters its next phase of growth.Members are expected to bring experience, perspective and valuable networks rather than operational involvement.Areas where advisors may contribute include:Commercial strategyHealthcare and clinical operationsMedical device commercialisationRegulatory and reimbursement strategyDistribution and channel partnershipsStrategic introductionsInternational expansionCorporate growthEngagement is flexible and strategic, with periodic interaction alongside the executive leadership team.WHO WE ARE LOOKING FORWe welcome applications from experienced individuals including:Former CEOs and foundersHealthcare executivesMedical device leadersHospital executivesDental service organisation leadersHealthcare operatorsInvestors with healthcare expertiseCommercial leaders within regulated industriesBoard members and non-executive directorsThe strongest candidates are typically individuals who have built, scaled, invested in, or advised high-growth companies operating in regulated markets.WHY THIS MOMENT IS DIFFERENTMany companies begin recruiting advisors before they have demonstrated meaningful commercial progress.Lumaegis is doing so at a point where multiple milestones are already in place.The company has:A defined FDA regulatory pathwayRegulatory progress continuing toward clearanceInitial commercial customer commitmentsInternational scientific recognitionStrategic expansion discussions in Asia-PacificA clear roadmap toward market launchThe Advisory Board is being expanded to support this transition from regulatory execution into commercial growth.OWNERSHIP ALIGNMENTThis Advisory Board is designed for individuals who believe strategic contribution and ownership should be aligned.Participation is equity-based rather than cash-compensated. xhyhwjd Members have the opportunity to contribute experience, relationships and strategic guidance while participating alongside the company's long-term growth.IDEAL EXPERIENCESuccessful applicants typically have experience in one or more of the following:HealthcareMedical devicesDentalClinical operationsHospital administrationHealthcare technologyInfection preventionCommercialisationCorporate strategyVenture investingPrivate equityScaling regulated businesses